Screening Or NO Screening: differences in survival during follow-up after random colorectal cancer screening with faecal occult blood test or no screening

ISRCTN ISRCTN94861265
DOI https://doi.org/10.1186/ISRCTN94861265
Secondary identifying numbers CRC02; NTR1010
Submission date
23/08/2007
Registration date
23/08/2007
Last edited
01/07/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr L.G.M. van Rossum
Scientific

Radboud University Nijmegen Medical Centre
Department of Gastroenterology and Hepatology
Nijmegen
6500 HB
Netherlands

Phone +31 (0)24 361 7272
Email L.vanRossum@mdl.umcn.nl

Study information

Study designRandomised active-controlled parallel-group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeScreening
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleScreening Or NO Screening: differences in survival during follow-up after random colorectal cancer screening with faecal occult blood test or no screening
Study acronymSONOS
Study objectivesSurvival after screening for colorectal cancer with faecal occult blood test is increased compared with no screening.

Please note that this is the follow-up trial to ISRCTN57917442: Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands.
Ethics approval(s)Ethics approval provisionally received from the Dutch Health Council, 03/11/2005, ref: 2005/03WBO
Health condition(s) or problem(s) studiedColorectal cancer screening with Faecal Occult Blood Test (FOBT)
InterventionFaecal occult blood test versus no test.

Timepoints (included in original trial - see hypothesis):
T0 = randomisation
T1 = invitation of the individuals randomised to the screening group
T2 = receive date of the test
T3 = evaluation date of the test in the laboratory
T4 = positive (including invitation for pre-colonoscopy consultation) or negative result letter
T5 = pre-colonoscopy consultation
T6 = colonoscopy
T7 = further treatment if necessary
T8 = start follow-up (for no screening group T8 starts immediately, for the screening group with negative test T8 is consecutive after T3)
T9 = follow-up 1 year
T10 = follow-up 2 years
T11 = follow-up 3 years
Intervention typeOther
Primary outcome measureSurvival

In each year of the follow-up (timepoints T9 - T11), the population will be censored for:
1. Mortality of colorectal cancer
2. Mortality of other causes
3. Other reasons for loss to follow-up
Secondary outcome measuresNo secondary outcome measures
Overall study start date01/09/2007
Completion date01/09/2017

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants20000
Key inclusion criteriaMen and women 50 to 75 years of age
Key exclusion criteriaLiving in an institution or similar
Date of first enrolment01/09/2007
Date of final enrolment01/09/2017

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Radboud University Nijmegen Medical Centre
Nijmegen
6500 HB
Netherlands

Sponsor information

University Medical Centre St. Radboud (Netherlands)
Hospital/treatment centre

Department of Gastroenterology and Hepatology
Nijmegen
6500 HB
Netherlands

Website http://www.umcn.nl/homepage
ROR logo "ROR" https://ror.org/05wg1m734

Funders

Funder type

Hospital/treatment centre

Radboud Universitair Medisch Centrum
Private sector organisation / Universities (academic only)
Alternative name(s)
Radboudumc, Radboud University Medical Center, Radboud University Nijmegen Medical Center, RUNMC
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan